The company is working with an adviser to gauge interest from potential buyers, the people said, asking not to be identified discussing confidential information. A sale may value Promasidor at about $1.5 billion, the people said.
Deliberations are in the early stages and Promasidor could decide against a sale if interest is muted, according to the people. Ajinomoto has made no decisions on its stake in Promasidor, a spokesperson for the Japanese ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.